Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Abstract Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with hydrangea red sensation one of the worst prognoses, with no targeted therapeutic strategies currently available.Regulated cell death (RCD), also known as programmed cell death (PCD), has been widely reported to have numerous links to the progression and therapy o